Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
3.520
+0.160 (4.76%)
Feb 21, 2025, 4:00 PM EST - Market closed
Scinai Immunotherapeutics Market Cap
Scinai Immunotherapeutics has a market cap or net worth of $3.00 million as of February 21, 2025. Its market cap has increased by 76.62% in one year.
Market Cap
3.00M
Enterprise Value
3.20M
1-Year Change
76.62%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since May 12, 2015, Scinai Immunotherapeutics's market cap has decreased from $11.20M to $3.00M, a decrease of -73.19%. That is a compound annual growth rate of -12.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.00M | 3.45% |
| Dec 31, 2024 | 2.90M | 31.82% |
| Dec 29, 2023 | 2.20M | -60.00% |
| Dec 30, 2022 | 5.50M | -83.68% |
| Dec 31, 2021 | 33.70M | 5.64% |
| Dec 31, 2020 | 31.90M | -65.85% |
| Dec 31, 2019 | 93.40M | 199.36% |
| Dec 31, 2018 | 31.20M | 72.38% |
| Dec 29, 2017 | 18.10M | 60.18% |
| Dec 30, 2016 | 11.30M | 0.89% |
| Dec 31, 2015 | 11.20M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |